Yonemoto Tsukasa, Ishii Takeshi, Takeuchi Yoshio, Hagiwara Yoko, Iwata Shintaro, Tatezaki Shin-Ichiro
Division of Orthopaedic Surgery, Chiba Cancer Center, 666-2 Nitona-cho, Chuo-ku, Chiba 260-8717, Japan.
Anticancer Res. 2009 Feb;29(2):763-7.
To investigate the marital status and fertility in long-term survivors of high-grade osteosarcoma.
We surveyed the marital rate (number of married persons/total number of persons) in 46 long-term survivors of osteosarcoma who were treated in our hospital between 1976 and 2002. In addition, we examined the fertility rate (number of persons having offspring/number of married persons) in 29 married patients. The participants were divided into 2 groups: one group (MC) in which moderate-dose chemotherapy was performed between 1976 and 1986; and another group (IC) in which intensive-dose chemotherapy was performed between 1987 and 2002. In each group, the fertility rate was investigated. As controls, we surveyed the marital and fertility rates in 52 siblings of the patients.
In the patients, the marital rate was 63.0% (29/46). There was no significant difference in the marital rate between the patients and their siblings. In the patients, the overall fertility rate was 58.6% (17/29). The fertility rate of male patients in the IC group (16.7%, 1/6) was significantly lower than that of their male siblings (76.5%, 13/17) (p = 0.018).
These results suggest that recently intensified chemotherapy for osteosarcoma affects fertility in long-term male survivors.
调查高级别骨肉瘤长期存活者的婚姻状况及生育情况。
我们调查了1976年至2002年期间在我院接受治疗的46例骨肉瘤长期存活者的结婚率(已婚人数/总人数)。此外,我们还检查了29例已婚患者的生育率(有子女的人数/已婚人数)。参与者分为两组:一组(MC)在1976年至1986年期间接受中剂量化疗;另一组(IC)在1987年至2002年期间接受大剂量化疗。在每组中,均对生育率进行了调查。作为对照,我们调查了患者的52名兄弟姐妹的婚姻率和生育率。
患者的结婚率为63.0%(29/46)。患者与其兄弟姐妹的结婚率无显著差异。患者的总体生育率为58.6%(17/29)。IC组男性患者的生育率(16.7%,1/6)显著低于其男性兄弟姐妹的生育率(76.5%,13/17)(p = 0.018)。
这些结果表明,近期骨肉瘤强化化疗会影响长期存活男性患者的生育能力。